Evidence map›Paper›PMID 12937339›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

WNT7a induces E-cadherin in lung cancer cells.

Tatsuo Ohira, Robert M Gemmill, Kevin Ferguson, Sophie Kusy, Joëlle Roche, Elisabeth Brambilla, Chan Zeng, Anna Baron, Lynne Bemis, Paul Erickson and 7 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01480141 (A Therapeutic Trial of Afatinib in the Neoadjuvant Setting. Molecular Effects of Afatinib), which is not on this map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01480141 phase2withdrawnnot on this mapstarted 2012, after this paper: background citation

A Therapeutic Trial of Afatinib in the Neoadjuvant Setting. Molecular Effects of Afatinib: A Window of Opportunity Trial In Early Stage NSCLC

TypeinterventionalSponsorMedical University of South CarolinaRan2012 to 2012Enrolled0ConditionsLung CancerArmsBIBW 2992 (Afatinib)
3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 179 citations in OpenAlex.

  1. Review
  2. The cross-talk between GSK-3β, RKIP, and PTEN as potential targets for therapeutic implications in cancer: a comprehensive insight.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Lithium: A Promising Anticancer Agent.Life (Basel, Switzerland) · 2023
    Review
  7. Characteristics of the TDRD1 gene promoter in chickens.Molecular genetics and genomics : MGG · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. More than a Genetic Code: Epigenetics of Lung Fibrosis.Molecular diagnosis & therapy · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Tatsuo OhiraDivision of Medical Oncology, Department of Biometrics/Preventive Medicine, University of Colorado Health Sciences and Cancer Centers, 4200 East 9th Avenue, Denver, CO 80262, USA.
Robert M Gemmill
Kevin Ferguson
Sophie Kusy
Joëlle Roche
Elisabeth Brambilla
Chan Zeng
Anna Baron
Lynne Bemis
Paul Erickson
Elizabeth Wilder
Anil Rustgi
Jan Kitajewski
Edward Gabrielson
Roy Bremnes
Wilbur Franklin
Harry A Drabkin
Université de Poitiers · FR

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Tissue Bank and Biomarkers CoreP50CA058187 · NCI · UNIVERSITY OF COLORADO DENVER · PI MILLER, YORK E · 1992 to 2018
$43.8M
Colorado Biomarkers Development LaboratoryU01CA085070 · NCI · UNIVERSITY OF COLORADO DENVER · PI FRANKLIN, WILBUR A · 1999 to 2009
$4.1M
NCI NIH HHS CA46934NCI NIH HHS CA58187NCI NIH HHS CA85070NCI NIH HHS P30 CA046934NCI NIH HHS P50 CA058187NCI NIH HHS U01 CA085070
6 · The paper itself

Abstract

E-cadherin loss in cancer is associated with de-differentiation, invasion, and metastasis. Drosophila DE-cadherin is regulated by Wnt/beta-catenin signaling, although this has not been demonstrated in mammalian cells. We previously reported that expression of WNT7a, encoded on 3p25, was frequently downregulated in lung cancer, and that loss of E-cadherin or beta-catenin was a poor prognostic feature. Here we show that WNT7a both activates E-cadherin expression via a beta-catenin specific mechanism in lung cancer cells and is involved in a positive feedback loop. Li+, a GSK3 beta inhibitor, led to E-cadherin induction in an inositol-independent manner. Similarly, exposure to mWNT7a specifically induced free beta-catenin and E-cadherin. Among known transcriptional suppressors of E-cadherin, ZEB1 was uniquely correlated with E-cadherin loss in lung cancer cell lines, and its inhibition by RNA interference resulted in E-cadherin induction. Pharmacologic reversal of E-cadherin and WNT7a losses was achieved with Li+, histone deacetylase inhibition, or in some cases only with combined inhibitors. Our findings provide support that E-cadherin induction by WNT/beta-catenin signaling is an evolutionarily conserved pathway operative in lung cancer cells, and that loss of WNT7a expression may be important in lung cancer development or progression by its effects on E-cadherin.

Indexed as

Proto-Oncogene ProteinsCadherinsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHistone DeacetylasesHomeodomain ProteinsHumansLithiumLung NeoplasmsProteinsTranscription FactorsTranscription, GeneticTumor Cells, CulturedWnt ProteinsZinc Finger E-box-Binding Homeobox 1CadherinsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHistone DeacetylasesHomeodomain ProteinsLithiumProteinsProto-Oncogene ProteinsTranscription FactorsWNT7A protein, humanWnt7a protein, mouseWnt ProteinsZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1

Identifiers

PMID12937339
PMCPMC193578
OpenAlexW2074974325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.